A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?

Abstract

The rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed.